Lipoprotein levels and cardiovascular risk in HIV-infected and uninfected Rwandan women.
BACKGROUND
Lipoprotein profiles in HIV-infected African women have not been well described. We assessed associations of lipoprotein levels and cardiovascular risk with HIV-infection and CD4 count in Rwandan women.


METHODS
Cross-sectional study of 824 (218 HIV-negative, 606 HIV+) Rwandan women. Body composition by body impedance analysis, CD4 count, and fasting serum total cholesterol (total-C), triglycerides (TG) and high-density lipoprotein (HDL) levels were measured. Low-density lipoprotein (LDL) was calculated from Friedewald equation if TG < 400 and measured directly if TG ≥ 400 mg/dl.


RESULTS
BMI was similar in HIV+ and -negative women, < 1% were diabetic, and HIV+ women were younger. In multivariate models LDL was not associated with HIV-serostatus. HDL was lower in HIV+ women (44 vs. 54 mg/dL, p < 0.0001) with no significant difference by CD4 count (p = 0.13). HIV serostatus (p = 0.005) and among HIV+ women lower CD4 count (p = 0.04) were associated with higher TG. BMI was independently associated with higher LDL (p = 0.01), and higher total body fat was strongly associated with higher total-C and LDL. Framingham risk scores were < 2% in both groups.


CONCLUSIONS
In this cohort of non-obese African women HDL and TG, but not LDL, were adversely associated with HIV infection. As HDL is a strong predictor of cardiovascular (CV) events in women, this HIV-associated difference may confer increased risk for CV disease in HIV-infected women.
Anastos
Kathryn
K
Montefiore Medical Center, Bronx NY, USA. kanastos@verizon.net.
Ndamage
François
F
Lu
Dalian
D
Cohen
Mardge H
MH
Shi
Qiuhu
Q
Lazar
Jason
J
Bigirimana
Venerand
V
Mutimura
Eugene
E
J Acquir Immune Defic Syndr. 2007 May 1;45(1):34-42
17460470
Clin Biochem. 2000 Oct;33(7):549-55
11124340
Metabolism. 2001 Mar;50(3):370-6
11230794
PLoS Med. 2004 Oct;1(1):e19
15526045
J Cardiovasc Risk. 2002 Dec;9(6):315-22
12478200
J Acquir Immune Defic Syndr. 2000 Jan 1;23(1):35-43
10708054
J Lipid Res. 1994 May;35(5):871-82
8071609
Metabolism. 2006 Jan;55(1):90-5
16324925
J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):304-11
18398971
Am J Cardiol. 2002 Oct 17;90(8A):77i-84i
12419484
Clin Chim Acta. 1998 Jun 8;274(1):63-70
9681598
Am J Med. 1993 May;94(5):515-519
7605397
JAMA. 2003 Jun 11;289(22):2978-82
12799406
N Engl J Med. 2007 Apr 26;356(17):1723-35
17460226
Circulation. 1989 Jan;79(1):8-15
2642759
Lipids. 2010 Jan;45(1):73-80
19916038
Eur J Clin Invest. 1994 Jun;24(6):416-20
7957495
AIDS. 2010 Jan 16;24(2):243-53
19996940
N Engl J Med. 2006 Nov 30;355(22):2283-96
17135583
J Acquir Immune Defic Syndr (1988). 1994 Nov;7(11):1149-56
7932082
J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):199-202
15905737
J Clin Endocrinol Metab. 1993 Mar;76(3):559-65
8445011
Am J Med. 1989 Jan;86(1):27-31
2910092
Lancet. 1999 Jun 19;353(9170):2093-9
10382692
J Clin Endocrinol Metab. 1992 May;74(5):1045-52
1373735